Marc Koska-A Social Entrepreneur on a Mission to `Auto-Disable` a Hidden Medical Crisis
| Case Code: LDEN235 Case Length: 16 Pages Period: 1983-2024 Pub Date: 2025 Teaching Note: Available |
Price: Rs.400 Organization : ApiJect Systems Corp Industry :Pharmaceuticals & Biotech Countries : United Kingdom Themes: Social Entrepreneurship, New Product Development, Advocacy Campaigns,Disruption |

Abstract Case Intro 1 Case Intro 2 Excerpts
Introduction
On May 6, 2024, a US-based medical technology public-benefit corporation , ApiJect Systems Corp. (ApiJect), in a press release congratulated its Co-Founder and Head of Product Design, Marc Andrew Koska (Koska), on the 40th anniversary of the invention of his “K1” Auto-Disable Syringe (ADS) (See Exhibit I for the “K1” Syringe). The “K1” was stated to have reduced the spread of blood borne diseases by preventing syringe reuse and was credited with having saved more than 20 million lives to date..
Buy this case study (Please select any one of the payment options)
| Price: Rs.400 |
Price: Rs.400 | PayPal (9 USD) |
Custom Search
